Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Bhamidipati

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Nature Communications|May 15, 2025
Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid TumorsMichael LaPelusa, Wei Qiao, Bryan Iorgulescu, et al.
American Journal of Clinical Oncology|April 12, 2019
Rapid Early Tumor Progression is Prognostic in Glioblastoma PatientsJoshua D Palmer, Deepak Bhamidipati, Gaurav Shukla, et al.
NPJ Precision Oncology|October 28, 2021
An analysis of research biopsy core variability from over 5000 prospectively collected core samplesDeepak Bhamidipati, Anuj Verma, Dawen Sui, et al.
Cancers|January 25, 2025
The Clinical Utility of a Next-Generation Sequencing-Based Approach to Detecting Circulating HPV DNA in Patients with Advanced Anal CancerDeepak Bhamidipati, Jay R Johnson, Kangyu Lin, et al.
Journal of Neuro-Oncology|January 10, 2018
Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Journal of Neuro-Oncology|December 14, 2017
Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2025
HER2-Positivity as a Prognostic Biomarker and Therapeutic Target in Advanced Biliary Tract Cancer: A Multi-Institutional AnalysisSunyoung S Lee, Dong Hyun Seo, Taek Chung, et al.
Journal of Neuro-Oncology|September 6, 2018
Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?Joshua D Palmer, Deepak Bhamidipati, Andrew Song, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2023
Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancerDaniel A Fox, Deepak Bhamidipati, Tsuyoshi Konishi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2025
Clinicogenomic Characterization of Primary Sclerosing Cholangitis-Associated Biliary Tract CancersXin Wang, Jaime Ivan Haro-Silerio, Felix Emile Gastonguay Beaudry, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nature Communications|May 15, 2025
Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid TumorsMichael LaPelusa, Wei Qiao, Bryan Iorgulescu, et al.
American Journal of Clinical Oncology|April 12, 2019
Rapid Early Tumor Progression is Prognostic in Glioblastoma PatientsJoshua D Palmer, Deepak Bhamidipati, Gaurav Shukla, et al.
NPJ Precision Oncology|October 28, 2021
An analysis of research biopsy core variability from over 5000 prospectively collected core samplesDeepak Bhamidipati, Anuj Verma, Dawen Sui, et al.
Cancers|January 25, 2025
The Clinical Utility of a Next-Generation Sequencing-Based Approach to Detecting Circulating HPV DNA in Patients with Advanced Anal CancerDeepak Bhamidipati, Jay R Johnson, Kangyu Lin, et al.
Journal of Neuro-Oncology|January 10, 2018
Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Journal of Neuro-Oncology|December 14, 2017
Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2025
HER2-Positivity as a Prognostic Biomarker and Therapeutic Target in Advanced Biliary Tract Cancer: A Multi-Institutional AnalysisSunyoung S Lee, Dong Hyun Seo, Taek Chung, et al.
Journal of Neuro-Oncology|September 6, 2018
Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?Joshua D Palmer, Deepak Bhamidipati, Andrew Song, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2023
Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancerDaniel A Fox, Deepak Bhamidipati, Tsuyoshi Konishi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2025
Clinicogenomic Characterization of Primary Sclerosing Cholangitis-Associated Biliary Tract CancersXin Wang, Jaime Ivan Haro-Silerio, Felix Emile Gastonguay Beaudry, et al.
Pageof 2